A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardship.

Détails

ID Serval
serval:BIB_EA57B66CFE2B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardship.
Périodique
The Journal of antimicrobial chemotherapy
Auteur⸱e⸱s
Yusuf E., Zeitlinger M., Meylan S.
ISSN
1460-2091 (Electronic)
ISSN-L
0305-7453
Statut éditorial
Publié
Date de publication
01/02/2023
Peer-reviewed
Oui
Volume
78
Numéro
2
Pages
338-345
Langue
anglais
Notes
Publication types: Review ; Journal Article
Publication Status: ppublish
Résumé
The interpretation of 'susceptible (S)' or 'resistant (R)' results of antimicrobial susceptibility testing is easily understood, but the interpretation of the 'intermediate (I)' category can be confusing. This review critically discusses how this categorization (clinical breakpoints) comes into being with the emphasis on the use of pharmacokinetics and pharmacodynamic data. It discusses the differences between the 'I' according to the CLSI and the EUCAST. This review also discusses the recent EUCAST change of the 'I' definition, and the impact of this change from laboratory and clinical points of view.
Mots-clé
Anti-Bacterial Agents/therapeutic use, Anti-Bacterial Agents/pharmacokinetics, Antimicrobial Stewardship, Microbial Sensitivity Tests, Laboratories
Pubmed
Web of science
Création de la notice
03/01/2023 5:47
Dernière modification de la notice
08/03/2023 6:46
Données d'usage